Skip to content
value.today

Brain+ A/S: peers

Change the peers

Brain+ A/S beside the 7 companies most like it by industry, size and country: every figure with its date and source, its rank in the group and its percentile in its sector and country.

Brain+ A/S, Monsenso A/S, Biodexa Pharmaceuticals plc, Virax Biolabs Group Limited, Stayble Therapeutics AB (publ), Lipidor AB (publ), Qlife Holding AB (publ), Lidds AB (publ): the market cap on file is more than 60 days old or a last known value (no market-data feed for their exchanges yet), so their valuation multiples and yields are shown but not ranked.

Side by side#

Every figure with its fiscal year or date and its source. Switch to each company's rank in the group, or its percentile in its sector or country. How ranks are worked out.

Brain+ A/S, Monsenso A/S, Biodexa Pharmaceuticals plc, Virax Biolabs Group Limited, Stayble Therapeutics AB (publ), Lipidor AB (publ), Qlife Holding AB (publ), Lidds AB (publ) side by side: each figure with its period and source, its rank among these companies and its percentile in the company's sector and country
MeasureBrain+ A/Sbase
BRAINP.CO · 🇩🇰 DK
Percentile in Healthcare
Percentile in Denmark
Monsenso A/S
MONSO.CO · 🇩🇰 DK
Percentile in Healthcare
Percentile in Denmark
Biodexa Pharmaceuticals plc
BDRX · 🇬🇧 GB
Percentile in Healthcare
Percentile in UK
Virax Biolabs Group Limited
VRAX · 🇬🇧 GB
Percentile in Healthcare
Percentile in UK
Stayble Therapeutics AB (publ)
STABL.ST · 🇸🇪 SE
Percentile in Healthcare
Percentile in Sweden
Lipidor AB (publ)
LIPI.ST · 🇸🇪 SE
Percentile in Healthcare
Percentile in Sweden
Qlife Holding AB (publ)
QLIFE.ST · 🇸🇪 SE
Percentile in Healthcare
Percentile in Sweden
Lidds AB (publ)
LIDDS.ST · 🇸🇪 SE
Percentile in Healthcare
Percentile in Sweden
Group median
Size
Market cap (Better neither way: ranked highest first)$1 Mlast known, Jan 5, 2024 · Market dataLast known value: no current one3rd of 8$1 Mlast known, Jan 5, 2024 · Market dataLast known value: no current one3rd of 8$1 MAug 1, 2026 · Market data2nd of 8$2 MAug 1, 2026 · Market data1st of 8$1 Mlast known, Jan 5, 2024 · Market dataLast known value: no current one3rd of 8$1 Mlast known, Jan 5, 2024 · Market dataLast known value: no current one3rd of 8$1 Mlast known, Jan 5, 2024 · Market dataLast known value: no current one3rd of 8$1 Mlast known, Jan 5, 2024 · Market dataLast known value: no current one3rd of 8$1 M8 ranked
Revenue (Better neither way: ranked highest first)——————$0 MFY2024 · SEConly one with it————————$0 M—
Net income (Higher is better)————$-8 MFY2025 · SEC2nd of 2$-6 MFY2024 · SEC1st of 2————————$-7 M2 ranked
Employees (Better neither way: ranked highest first)——————26March 31, 2026 · Profileonly one with it————————26—
Margins and returns
Return on equity (Higher is better)————————-65.2%FY2025 · SEC1st of 236th5th-109.5%FY2024 · SEC2nd of 222nd3rd————————————————-87.4%2 ranked
Valuation
Price to sales (Better neither way: ranked highest first)————————————200.0×price Aug 1, 2026 · Market datanot ranked: old priceold priceold price——————————————————
Price to book (Better neither way: ranked highest first)————————0.1×price Aug 1, 2026 · Market datanot ranked: old priceold priceold price0.3×price Aug 1, 2026 · Market datanot ranked: old priceold priceold price——————————————————
Scorecard
Scorecard (Higher is better)————1 of 6FY2025 · Scorecard1st of 21 of 8FY2024 · Scorecard2nd of 2————————15% passed2 ranked
Growth checks (Higher is better)————1 of 2FY2025 · Scorecard1st of 20 of 1FY2024 · Scorecard2nd of 2————————25% passed2 ranked
Profitability checks (Higher is better)————0 of 3FY2025 · Scorecard1st of 20 of 3FY2024 · Scorecard1st of 2————————0% passed2 ranked
Financial health checks (Higher is better)————0 of 1FY2025 · Scorecard2nd of 21 of 3FY2024 · Scorecard1st of 2————————17% passed2 ranked
Shareholder returns checks (Higher is better)——————0 of 1FY2024 · Scorecardonly one with it————————0% passed—
Ownership
Held by institutions (Better neither way: ranked highest first)————11.2%2026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in1st of 24.9%2026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in2nd of 2————————8.1%2 ranked
Institutions holding (Better neither way: ranked highest first)————62026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in1st of 242026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in2nd of 2————————52 ranked

Under each figure: its fiscal year, quarter or date, and its source. ↑ higher is better, ↓ lower is better, · better neither way (ranked highest first). Ranks count only the companies with the figure; percentiles place each company among all the companies of its own sector and country with the figure (ten or more needed).

† The market cap behind this figure is more than 60 days old (no market-data feed for that exchange yet): it is shown but not ranked or given a percentile.

Sources: SEC = SEC annual reports (10-K, 20-F, 40-F); ESEF = ESEF annual reports (European and UK listed companies); Editors = The company's annual report, entered by value.today editors; Wikidata = Wikidata, citing the annual report; Scorecard = value.today scorecard: thirty checks on the company's statements, worked out daily; 13F = SEC Form 13F holdings reports; SEC = Dividends declared per share in SEC 10-Q and 10-K filings; Profile = The company's latest reported headcount; Market data = Brain+ A/S: How market caps are worked out; Monsenso A/S: How market caps are worked out; Biodexa Pharmaceuticals plc: How market caps are worked out; Virax Biolabs Group Limited: How market caps are worked out; Stayble Therapeutics AB (publ): How market caps are worked out; Lipidor AB (publ): How market caps are worked out; Qlife Holding AB (publ): How market caps are worked out; Lidds AB (publ): How market caps are worked out.

Where each stands in its sector and country: Return on equity#

The dot is the company; the line runs from the 10th to the 90th percentile of all the companies of its sector (or country) with the figure, the box holds the middle half and the tick is the median. Each company's newest fiscal year; figures that divide by the market value only with a market cap at most 60 days old. How percentiles are worked out.

Return on equity: each company's figure and its percentile in its sector and its country
CompanyReturn on equityIn its sectorIn its country
Brain+ A/S———
Monsenso A/S———
Biodexa Pharmaceuticals plc-65.2%FY2025
36th percentile in Healthcaremedian -36.9%, 977 companies
5th percentile in UKmedian 7.7%, 417 companies
Virax Biolabs Group Limited-109.5%FY2024
22nd percentile in Healthcaremedian -36.9%, 977 companies
3rd percentile in UKmedian 7.7%, 417 companies
Stayble Therapeutics AB (publ)———
Lipidor AB (publ)———
Qlife Holding AB (publ)———
Lidds AB (publ)———

Revenue by fiscal year, and the rank in the group#

Revenue of the fiscal year. US dollars at each year's exchange rate; fiscal years as each company names them. Ranks: 1st is the highest (better neither way).

Revenue

$0 M$1 M$1 M$2 M$3 M2016201720182019202020212022202320242025Biodexa Pharmaceuticals plc $0 MVirax Biolabs Group Limited $0 M

Rank in the group

1st2nd20202022Biodexa Pharmaceuticals plc: 1st of 2 in 2020Biodexa Pharmaceuticals plc: 1st of 2 in 2022Biodexa Pharmaceuticals plVirax Biolabs Group Limited: 2nd of 2 in 2020Virax Biolabs Group Limited: 2nd of 2 in 2022Virax Biolabs Group Limite
Revenue by fiscal year with each company's rank in the group and the source of each figure
Fiscal yearBrain+ A/SMonsenso A/SBiodexa Pharmaceuticals plcVirax Biolabs Group LimitedStayble Therapeutics AB (publ)Lipidor AB (publ)Qlife Holding AB (publ)Lidds AB (publ)
2024———$0 MSEC————
2023——$0 MSEC—————
2022——$1 MSEC1st$0 MSEC2nd————
2021——$1 MSEC—————
2020——$0 MSEC1st$0 MSEC2nd————
2019——$1 MSEC—————
2018——$3 MSEC—————
2017——$1 MSEC—————
2016——$2 MSEC—————
2015——$2 MSEC—————

Sources: SEC = SEC annual reports (10-K, 20-F, 40-F); ESEF = ESEF annual reports (European and UK listed companies); Ed. = The company's annual report, entered by value.today editors; WD = Wikidata, citing the annual report; Cap = value.today market caps (the last of each calendar year). The small ordinal is the rank in the group that year. Hover a figure for its fiscal year end.

Suggested peers of Brain+ A/S#

Companies of the same industry first, then the same sector, within a hundred times its size (market cap), scored out of 100 for industry, size, country and figures on file. How peers are suggested.

  • Monsenso A/SMONSO.CO · 🇩🇰 Denmark
    Same sector: Healthcare (Healthcare Information Services) · Similar size: $1 M market cap against $1 M · Same country: Denmark
    Market cap $1 M (last known, Jan 5, 2024)
    70 of 100 (industry or sector 25 + size 30 + country 15)
    In the group
  • Biodexa Pharmaceuticals plcBDRX · 🇬🇧 UK
    Same sector: Healthcare (Biotechnology) · Similar size: $1 M market cap against $1 M · Same region: Northern Europe · Ratios of the last two fiscal years on file
    Market cap $1 M (Aug 1, 2026)
    66 of 100 (industry or sector 25 + size 29 + country 7 + figures on file 5)
    In the group
  • Virax Biolabs Group LimitedVRAX · 🇬🇧 UK
    Same sector: Healthcare (Diagnostics and Research) · Similar size: $2 M market cap against $1 M · Same region: Northern Europe · Ratios of the last two fiscal years on file
    Market cap $2 M (Aug 1, 2026) · revenue $0 M (year to March 2025)
    62 of 100 (industry or sector 25 + size 26 + country 7 + figures on file 5)
    In the group
  • Stayble Therapeutics AB (publ)STABL.ST · 🇸🇪 Sweden
    Same sector: Healthcare (Biotechnology) · Similar size: $1 M market cap against $1 M · Same region: Northern Europe
    Market cap $1 M (last known, Jan 5, 2024)
    62 of 100 (industry or sector 25 + size 30 + country 7)
    In the group
  • Lipidor AB (publ)LIPI.ST · 🇸🇪 Sweden
    Same sector: Healthcare (Pharmaceutical) · Similar size: $1 M market cap against $1 M · Same region: Northern Europe
    Market cap $1 M (last known, Jan 5, 2024)
    62 of 100 (industry or sector 25 + size 30 + country 7)
    In the group
  • Qlife Holding AB (publ)QLIFE.ST · 🇸🇪 Sweden
    Same sector: Healthcare (Medical Devices) · Similar size: $1 M market cap against $1 M · Same region: Northern Europe
    Market cap $1 M (last known, Jan 5, 2024)
    62 of 100 (industry or sector 25 + size 30 + country 7)
    In the group
  • Lidds AB (publ)LIDDS.ST · 🇸🇪 Sweden
    Same sector: Healthcare (Biotechnology) · Similar size: $1 M market cap against $1 M · Same region: Northern Europe
    Market cap $1 M (last known, Jan 5, 2024)
    62 of 100 (industry or sector 25 + size 30 + country 7)
    In the group
  • Diagonal Bio AB (publ)DIABIO.ST · 🇸🇪 Sweden
    Same sector: Healthcare (Biotechnology) · Similar size: $1 M market cap against $1 M · Same region: Northern Europe
    Market cap $1 M (last known, Jan 5, 2024)
    62 of 100 (industry or sector 25 + size 30 + country 7)
    + Add
  • Idogen AB (publ)IDOGEN.ST · 🇸🇪 Sweden
    Same sector: Healthcare (Biotechnology) · Similar size: $1 M market cap against $1 M · Same region: Northern Europe
    Market cap $1 M (last known, Dec 25, 2022)
    62 of 100 (industry or sector 25 + size 30 + country 7)
    + Add
  • Promore Pharma AB (publ)PROMO.ST · 🇸🇪 Sweden
    Same sector: Healthcare (Biotechnology) · Similar size: $1 M market cap against $1 M · Same region: Northern Europe
    Market cap $1 M (last known, Jan 5, 2024)
    62 of 100 (industry or sector 25 + size 30 + country 7)
    + Add
  • Pharmacolog I Uppsala AB (publ)PHLOG-B.ST · 🇸🇪 Sweden
    Same sector: Healthcare (Medical Equipment) · Similar size: $1 M market cap against $1 M · Same region: Northern Europe
    Market cap $1 M (last known, Jul 30, 2023)
    62 of 100 (industry or sector 25 + size 30 + country 7)
    + Add
  • Pharmiva AB (publ)PHARM.ST · 🇸🇪 Sweden
    Same sector: Healthcare (Biotechnology) · Similar size: $1 M market cap against $1 M · Same region: Northern Europe
    Market cap $1 M (last known, Jul 30, 2023)
    62 of 100 (industry or sector 25 + size 30 + country 7)
    + Add

Any figure over the years, other peers or a saved group: open this group in the peer workspace.